BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 24291707)

  • 1. Common decision limits --The need for harmonised immunoassays.
    Sturgeon CM
    Clin Chim Acta; 2014 May; 432():122-6. PubMed ID: 24291707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Standardisation of cardiac troponin I measurement: past and present.
    Tate JR; Bunk DM; Christenson RH; Katrukha A; Noble JE; Porter RA; Schimmel H; Wang L; Panteghini M;
    Pathology; 2010; 42(5):402-8. PubMed ID: 20632814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Traceability to a common standard for protein measurements by immunoassay for in-vitro diagnostic purposes.
    Thienpont LM; Van Houcke SK
    Clin Chim Acta; 2010 Dec; 411(23-24):2058-61. PubMed ID: 20831866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sample to sample carryover: a source of analytical laboratory error and its relevance to integrated clinical chemistry/immunoassay systems.
    Armbruster DA; Alexander DB
    Clin Chim Acta; 2006 Nov; 373(1-2):37-43. PubMed ID: 16777083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carryover: More than just a major hangover for the clinical laboratory.
    Kavsak PA; Zeidler J
    Clin Biochem; 2016 Jul; 49(10-11):735-6. PubMed ID: 27220058
    [No Abstract]   [Full Text] [Related]  

  • 6. Preparation, calibration and evaluation of the First International Standard for human C-peptide.
    Moore M; Dougall T; Ferguson J; Rigsby P; Burns C
    Clin Chem Lab Med; 2017 Jul; 55(8):1224-1233. PubMed ID: 28593916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Traceability and standardization of immunoassays: a major challenge.
    Morris HA
    Clin Biochem; 2009 Mar; 42(4-5):241-5. PubMed ID: 19863913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparability of tumor marker immunoassays: still an important issue for clinical diagnostics?
    Meany DL; Chan DW
    Clin Chem Lab Med; 2008; 46(5):575-6. PubMed ID: 18598200
    [No Abstract]   [Full Text] [Related]  

  • 9. Standardization of high-sensitivity immunoassays for measurement of C-reactive protein; II: Two approaches for assessing commutability of a reference material.
    Kimberly MM; Caudill SP; Vesper HW; Monsell EA; Miller WG; Rej R; Rifai N; Dati F; Myers GL
    Clin Chem; 2009 Feb; 55(2):342-50. PubMed ID: 19074518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Objective determination of appropriate reporting intervals.
    Badrick T; Wilson SR; Dimeski G; Hickman PE
    Ann Clin Biochem; 2004 Sep; 41(Pt 5):385-90. PubMed ID: 15333190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Control and standard substances for dry chemistry].
    Naka H
    Rinsho Byori; 1997 Nov; Suppl():155-62. PubMed ID: 9508600
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of four methods of establishing control limits for monitoring quality controls in infectious disease serology testing.
    Dimech W; Karakaltsas M; Vincini GA
    Clin Chem Lab Med; 2018 Oct; 56(11):1970-1978. PubMed ID: 29794255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Issues on standardization of immunoassays for prostate-specific antigen: a review.
    Graves HC
    Clin Invest Med; 1993 Dec; 16(6):415-24. PubMed ID: 7516830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reference measurement procedure corrected all method trimmed mean - The best of two worlds.
    Goossens K; Thienpont LM
    Clin Chim Acta; 2015 Feb; 440():55-6. PubMed ID: 25447697
    [No Abstract]   [Full Text] [Related]  

  • 15. Evidence-based laboratory medicine - a guide for critical evaluation of in vitro laboratory testing.
    Christenson RH;
    Ann Clin Biochem; 2007 Mar; 44(Pt 2):111-30. PubMed ID: 17362577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Issues in immunoassay standardization: the ARCHITECT Folate model for intermethod harmonization.
    Wilson DH; Williams G; Herrmann R; Wiesner D; Brookhart P
    Clin Chem; 2005 Apr; 51(4):684-7. PubMed ID: 15788785
    [No Abstract]   [Full Text] [Related]  

  • 17. Current parathyroid hormone immunoassays do not adequately meet the needs of patients with chronic kidney disease.
    Almond A; Ellis AR; Walker SW;
    Ann Clin Biochem; 2012 Jan; 49(Pt 1):63-7. PubMed ID: 22096021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reference measurement systems in clinical chemistry.
    Thienpont LM; Van Uytfanghe K; De Leenheer AP
    Clin Chim Acta; 2002 Sep; 323(1-2):73-87. PubMed ID: 12135808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Standardization of FSH, LH and hCG--current position and future prospects.
    Sturgeon CM; Ellis AR
    Mol Cell Endocrinol; 2007 Jan; 260-262():301-9. PubMed ID: 17113221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Easy fix for clinical laboratories for the false-positive defect with the Abbott AxSym total beta-hCG test.
    Cole LA; Khanlian SA
    Clin Biochem; 2004 May; 37(5):344-9. PubMed ID: 15087248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.